Skip to main content


Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Degludec: the new ultra-long insulin analogue

Fig. 4

Mean values of HbA1c observed in the 9 therapeutic confirmatory trials at baseline and at end of trial (EOT) for insulin degludec (IDeg) and comparators (insulin glargin, except in trials 3585 [insulin determir] and 3580 [sitagliptin]). FF: Fixed-flexible schedule; OADs: oral antidiabetic drugs; T1D: Type 1 diabetes; T2D: Type 2 diabetes. Adapted from Reference [15]

Back to article page